Total Payments
$1.8M
2024 Payments
$462,406
Companies
41
Transactions
2,180
Medicare Patients
6,196
Medicare Billing
$969,706
Payment Breakdown by Category
Other$1.2M (66.1%)
Consulting$339,265 (18.4%)
Travel$239,814 (13.0%)
Food & Beverage$42,693 (2.3%)
Research$3,712 (0.2%)
Education$83.30 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.2M | 415 | 64.1% |
| Consulting Fee | $339,265 | 116 | 18.4% |
| Travel and Lodging | $239,814 | 746 | 13.0% |
| Food and Beverage | $42,693 | 866 | 2.3% |
| Honoraria | $35,566 | 23 | 1.9% |
| Unspecified | $3,712 | 8 | 0.2% |
| Education | $83.30 | 6 | 0.0% |
Payments by Type
General
$1.8M
2,172 transactions
Research
$3,712
7 transactions
Ownership
$0
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $631,531 | 654 | $0 (2024) |
| GENZYME CORPORATION | $391,165 | 307 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $306,732 | 377 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $253,845 | 339 | $0 (2024) |
| Optinose US, Inc. | $54,246 | 76 | $0 (2024) |
| Incyte Corporation | $51,501 | 83 | $0 (2024) |
| Dermavant Sciences, Inc. | $30,560 | 23 | $0 (2024) |
| Aimmune Therapeutics, Inc. | $28,012 | 29 | $0 (2022) |
| Regeneron Pharmaceuticals, Inc. | $26,593 | 26 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $21,886 | 34 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $462,406 | 484 | AstraZeneca Pharmaceuticals LP ($141,752) |
| 2023 | $309,055 | 391 | GENZYME CORPORATION ($117,322) |
| 2022 | $276,045 | 316 | Regeneron Healthcare Solutions, Inc. ($133,447) |
| 2021 | $169,654 | 137 | Teva Pharmaceuticals USA, Inc. ($56,606) |
| 2020 | $96,173 | 120 | Regeneron Healthcare Solutions, Inc. ($39,271) |
| 2019 | $257,848 | 254 | Regeneron Healthcare Solutions, Inc. ($136,107) |
| 2018 | $131,397 | 227 | Teva Pharmaceuticals USA, Inc. ($47,695) |
| 2017 | $141,562 | 251 | Teva Pharmaceuticals USA, Inc. ($133,439) |
All Payment Transactions
2,180 individual payment records from CMS Open Payments — Page 1 of 88
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Incyte Corporation | OPZELURA (Drug) | Travel and Lodging | Cash or cash equivalent | $69.68 | General |
| Category: Dermatology | ||||||
| 12/18/2024 | Incyte Corporation | OPZELURA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,370.00 | General |
| Category: Dermatology | ||||||
| 12/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,647.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,700.00 | General |
| Category: Respiratory | ||||||
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,400.00 | General |
| Category: Respiratory | ||||||
| 12/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: Respiratory | ||||||
| 12/13/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $169.07 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/13/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $169.07 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/13/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $15.70 | General |
| Category: Oncology / Rare Diseases | ||||||
| 12/11/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $115.11 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $7,913.00 | General |
| Category: Immunology | ||||||
| 12/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $691.94 | General |
| Category: Immunology | ||||||
| 12/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $281.95 | General |
| Category: Immunology | ||||||
| 12/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $275.72 | General |
| Category: Immunology | ||||||
| 12/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | Cash or cash equivalent | $62.98 | General |
| Category: Immunology | ||||||
| 12/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | Cash or cash equivalent | $30.92 | General |
| Category: Immunology | ||||||
| 12/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | Cash or cash equivalent | $15.00 | General |
| Category: Immunology | ||||||
| 12/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $25.54 | General |
| Category: Respiratory | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Travel and Lodging | In-kind items and services | $337.09 | General |
| Category: Respiratory | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $118.77 | General |
| Category: Respiratory | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Travel and Lodging | In-kind items and services | $113.90 | General |
| Category: Respiratory | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Travel and Lodging | In-kind items and services | $53.00 | General |
| Category: Respiratory | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $102.78 | General |
| Category: Respiratory | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Travel and Lodging | In-kind items and services | $41.54 | General |
| Category: Respiratory | ||||||
| 12/03/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Honoraria | Cash or cash equivalent | $1,042.00 | General |
| Category: Oncology / Rare Diseases | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Expert consensus on SABA use for asthma clinical decision-making: a Delphi approach | Teva Pharmaceuticals USA, Inc. | $1,524 | 4 |
| US expert consensus on short-acting beta-agonist reliever medication use for asthma clinical decision-making: a mixed-method Delphi adjudication approach | Teva Pharmaceuticals USA, Inc. | $1,306 | 1 |
| US Expert Consensus On Short-acting Beta Agonist (SABA) Reliever Medication Use For Asthma Clinical Decision-making: A Mixed-method Delphi Adjudication Approach | Teva Pharmaceuticals USA, Inc. | $881.00 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,394 | 18,846 | $803,942 | $233,089 |
| 2022 | 18 | 1,588 | 21,730 | $866,679 | $251,696 |
| 2021 | 18 | 1,655 | 21,933 | $877,501 | $264,286 |
| 2020 | 16 | 1,559 | 20,005 | $791,235 | $220,635 |
Total Patients
6,196
Total Services
82,514
Medicare Billing
$969,706
Procedure Codes
68
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 2 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 150 | 237 | $30,810 | $4,954 | 16.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 25 | 249 | $13,446 | $2,764 | 20.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 27 | 27 | $5,130 | $2,203 | 42.9% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 27 | 31 | $3,875 | $1,252 | 32.3% |
| 95115 | Professional service for single injection of allergen | Office | 2022 | 16 | 136 | $4,352 | $986.31 | 22.7% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2022 | 37 | 47 | $1,410 | $714.26 | 50.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 11 | 12 | $720.00 | $709.20 | 98.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 19 | 21 | $3,570 | $628.31 | 17.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 12 | 13 | $364.00 | $358.40 | 98.5% |
| 95165 | Preparation and provision of single or multiple antigens for allergen immunotherapy | Office | 2021 | 302 | 7,727 | $353,258 | $102,625 | 29.1% |
| 95117 | Injection of incremental dosages of allergen, 2 or more injections | Office | 2021 | 316 | 5,132 | $256,548 | $43,944 | 17.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 211 | 335 | $55,275 | $31,794 | 57.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 212 | 296 | $37,000 | $19,036 | 51.4% |
| 95004 | Injection of allergenic extracts into skin, accessed through the skin | Office | 2021 | 81 | 5,509 | $45,449 | $18,323 | 40.3% |
| 95024 | Injection of allergenic extracts into skin for immediate reaction analysis | Office | 2021 | 62 | 1,797 | $22,463 | $13,092 | 58.3% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 22 | 251 | $18,825 | $11,049 | 58.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 39 | 39 | $9,165 | $4,934 | 53.8% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2021 | 147 | 194 | $25,220 | $4,360 | 17.3% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Office | 2021 | 80 | 101 | $17,170 | $3,647 | 21.2% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 48 | 48 | $9,120 | $3,133 | 34.4% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 22 | 252 | $13,608 | $2,828 | 20.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 31 | 34 | $5,610 | $2,365 | 42.2% |
| 95115 | Injection of incremental dosages of allergen | Office | 2021 | 17 | 151 | $4,832 | $1,077 | 22.3% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 12 | 12 | $720.00 | $720.00 | 100.0% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 17 | 17 | $2,125 | $705.90 | 33.2% |
About Dr. Gregory Bensch, M.D
Dr. Gregory Bensch, M.D is a Specialist healthcare provider based in Stockton, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1710950589.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Bensch, M.D has received a total of $1.8M in payments from pharmaceutical and medical device companies, with $462,406 received in 2024. These payments were reported across 2,180 transactions from 41 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1.2M).
As a Medicare-enrolled provider, Bensch has provided services to 6,196 Medicare beneficiaries, totaling 82,514 services with total Medicare billing of $969,706. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Stockton, CA
- Active Since 02/10/2006
- Last Updated 07/08/2007
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1710950589
Products in Payments
- DUPIXENT (Biological) $865,285
- CINQAIR (Drug) $141,269
- AIRSUPRA (Drug) $127,568
- TEZSPIRE (Biological) $88,381
- CINQAIR (Biological) $63,681
- DUPIXENT (Drug) $62,549
- Xhance (Drug) $54,246
- OPZELURA (Drug) $51,501
- DUPIXENT DUPILUMAB INJECTION (Biological) $50,590
- ProAir Digihaler (Drug) $31,577
- PALFORZIA (Biological) $28,012
- AYVAKIT (Drug) $21,789
- VTAMA (Drug) $17,146
- PROAIR (Drug) $14,754
- TAPINAROF (Drug) $13,414
- BEVESPI AEROSPHERE (Drug) $13,064
- FASENRA (Drug) $12,119
- QVAR (Drug) $11,035
- AirDuo RespiClick (Drug) $9,531
- PROAIR RESPICLICK (Drug) $7,000
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Stockton
George Bensch, M.d, M.D
Specialist — Payments: $144,679
Specialist $144,679
Dr. Ajithkumar Puthillath, Md, MD
Specialist — Payments: $33,046
Specialist $33,046
Prasad Dighe, Md, MD
Specialist — Payments: $13,978
Specialist $13,978
Aminder Mehdi, Md, MD
Specialist — Payments: $10,156
Specialist $10,156
Josebelo Chong, Md, MD
Specialist — Payments: $7,732
Specialist $7,732
Dean Karnaze, Md, MD
Specialist — Payments: $5,510
Specialist $5,510